The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,296.00
Bid: 12,322.00
Ask: 12,324.00
Change: -108.00 (-0.87%)
Spread: 2.00 (0.016%)
Open: 12,334.00
High: 12,362.00
Low: 12,250.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 8-UK rolls out AstraZeneca shots but PM Johnson poised to tighten restrictions

Mon, 04th Jan 2021 07:57

* UK first to roll out AstraZeneca vaccine

* PM Johnson set to announce tougher restrictions

* 82-year-old dialysis patient is first to get shot

* UK hails British scientific 'triumph'

* Concerns grow over South African variant
(Combines stories)

By Alistair Smout and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - Britain became the first country
to vaccinate its population with Oxford University and
AstraZeneca's COVID-19 shot on Monday, but Prime
Minister Boris Johnson was set to tighten restrictions in
England in an bid to slow the spread of cases.

Johnson will make a televised address at 8 p.m. (2000 GMT)
and parliament will be recalled on Wednesday.

"The spread of the new variant of COVID-19 has led to
rapidly escalating case numbers across the country," a spokesman
from the prime minister's office said.

"The prime minister is clear that further steps must now be
taken to arrest this rise and to protect the NHS (National
Health Service) and save lives. He will set those out this
evening."

Against the ominous backdrop of record daily cases, Britain
touted a scientific "triumph" as dialysis patient Brian Pinker,
82, became the first person to get the Oxford/AstraZeneca shot
outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
Pinker, a retired maintenance manager, just a few hundred metres
from where the vaccine was developed.

Britain is grappling with the world's sixth highest death
toll and one of the worst economic hits from the COVID-19
crisis. More than 75,000 people in the United Kingdom have died
from COVID-19 within 28 days of a positive test.

It was the first country to roll out the vaccine developed
by Pfizer and Germany's BioNTech almost a
month ago, and is prioritising getting a first dose of vaccines
to as many people as possible over giving second doses.

Some experts say they are worried about such an approach.

Two new variants of the coronavirus are complicating the
COVID-19 response and Britain has seen a resurgence in cases to
new daily highs.

UK scientists have expressed concern that COVID-19 vaccines
being rolled out may not be able to protect against a new
variant of the coronavirus that emerged in South Africa and has
spread internationally.

Johnson warned of "tough, tough weeks" ahead.

"If you look at the numbers, there's no question that we're
going to have to take tougher measures," Johnson said on a visit
to see health workers receiving the Oxford vaccine.

RESTRICTIONS GETTING TOUGHER

ITV News said the toughest Tier 4 level of restrictions,
which currently cover much of England, will be imposed across
the country and schools would be closed.

Moving ahead of Johnson, Scottish First Minister Nicola
Sturgeon imposed the most stringent lockdown since last spring.

"It is no exaggeration to say that I am more concerned about
the situation that we face now than I have been at any time
since March," she said.

Britain has administered more than a million COVID-19
vaccines - more than the rest of Europe put together, Health
Secretary Matt Hancock said, declaring it a triumph of British
science.

Johnson's government has secured 100 million doses of the
Oxford/AstraZeneca vaccine which can be stored at fridge
temperatures between two to eight degrees, making it easier to
distribute than the Pfizer shot.

Six hospitals in England are administering the first of
around 530,000 doses Britain has ready. The programme will be
expanded to hundreds of other British sites in coming days, and
the government hopes it will deliver tens of millions of doses
within months.

The U.S. Centers for Disease Control and Prevention said it
had administered 4.2 million first doses of COVID-19 vaccines as
of Saturday morning and distributed 13.07 million doses.

More than a tenth of Israel's population have had a vaccine
and it is now administering more than 150,000 doses a day.

Germany and Denmark are looking into the possibility of
delaying administering a second dose of the Pfizer vaccine to
make scarce supplies go further, after a similar move by
Britain.

Britain became the first Western country to approve and roll
out a COVID-19 vaccine, although it is behind Russia and China
which have been inoculating their citizens for months.
(Additional reporting by Elizabeth Piper, Writing by William
James, Guy Faulconbridge and Alistair Smout; Editing by Kate
Holton, Nick Macfie and Mike Collett-White)

More News
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.